Addus HomeCare (NASDAQ:ADUS) Director Sells $23,250.00 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of Addus HomeCare stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $93.00, for a total value of $23,250.00. Following the transaction, the director owned 3,450 shares in the company, valued at $320,850. This trade represents a 6.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Addus HomeCare Stock Performance

NASDAQ ADUS traded down $0.50 on Thursday, hitting $93.26. 158,172 shares of the company traded hands, compared to its average volume of 247,104. The company has a market capitalization of $1.74 billion, a price-to-earnings ratio of 17.24, a P/E/G ratio of 1.27 and a beta of 0.92. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The business’s 50 day moving average price is $96.10 and its 200-day moving average price is $105.73. Addus HomeCare Corporation has a 52-week low of $89.76 and a 52-week high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.10. The company had revenue of $363.50 million for the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.Addus HomeCare’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.42 earnings per share. Equities analysts expect that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently made changes to their positions in ADUS. Capital Research Global Investors increased its stake in Addus HomeCare by 22.3% during the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after acquiring an additional 268,192 shares during the last quarter. Freestone Grove Partners LP increased its stake in Addus HomeCare by 5,035.2% during the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after acquiring an additional 135,246 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after acquiring an additional 78,415 shares during the last quarter. 8 Knots Management LLC bought a new stake in Addus HomeCare during the third quarter worth approximately $6,075,000. Finally, Empowered Funds LLC increased its stake in Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after acquiring an additional 46,137 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ADUS. Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday, February 25th. Barclays lowered their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Finally, Stephens lowered their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $131.22.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.